Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando C Fervenza

Showing results (31-40 of 350) with videos related to

Pageof 35
Sort By:
Kidney International Reports|March 20, 2023
"Precision" Medicine in Membranous Nephropathy: Serology-Guided TherapyRichard J Glassock, Fernando C Fervenza
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2025
Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?Shane A Bobart, Fernando C Fervenza
The New England Journal of Medicine|October 24, 2019
Rituximab or Cyclosporine for Membranous Nephropathy. ReplyFernando C Fervenza, Daniel C Cattran
Journal of the American Society of Nephrology : JASN|May 16, 2022
Molecular Characterization of Membranous Nephropathy: <i>Quo Vadis?</i>Fernando C Fervenza, Richard J Glassock
Mayo Clinic Proceedings|February 4, 2018
Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A Nath, Fernando C Fervenza
American Journal of Nephrology|June 1, 2018
Membranous Nephropathy: Approaches to TreatmentAndrew S Bomback, Fernando C Fervenza
Expert Review of Clinical Immunology|August 14, 2012
Rituximab: emerging treatment strategies of immune-mediated glomerular diseaseAndrea G Kattah, Fernando C Fervenza
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 22, 2015
Opponent's commentsAn S De Vriese, Fernando C Fervenza
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 19, 2025
What's New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A ReviewLadan Zand, Fernando C Fervenza, Sanjeev Sethi
Kidney International Reports|June 9, 2025
High Temperature Requirement Protein A1-Positive Membranous Nephropathy in a Patient With Chronic Lymphocytic LeukemiaLadan Zand, Fernando C Fervenza, Sanjeev Sethi
Pageof 35

Showing results (31-40 of 350) with videos related to

Sort By:
Pageof 35
Kidney International Reports|March 20, 2023
"Precision" Medicine in Membranous Nephropathy: Serology-Guided TherapyRichard J Glassock, Fernando C Fervenza
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2025
Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?Shane A Bobart, Fernando C Fervenza
The New England Journal of Medicine|October 24, 2019
Rituximab or Cyclosporine for Membranous Nephropathy. ReplyFernando C Fervenza, Daniel C Cattran
Journal of the American Society of Nephrology : JASN|May 16, 2022
Molecular Characterization of Membranous Nephropathy: <i>Quo Vadis?</i>Fernando C Fervenza, Richard J Glassock
Mayo Clinic Proceedings|February 4, 2018
Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A Nath, Fernando C Fervenza
American Journal of Nephrology|June 1, 2018
Membranous Nephropathy: Approaches to TreatmentAndrew S Bomback, Fernando C Fervenza
Expert Review of Clinical Immunology|August 14, 2012
Rituximab: emerging treatment strategies of immune-mediated glomerular diseaseAndrea G Kattah, Fernando C Fervenza
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 22, 2015
Opponent's commentsAn S De Vriese, Fernando C Fervenza
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 19, 2025
What's New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A ReviewLadan Zand, Fernando C Fervenza, Sanjeev Sethi
Kidney International Reports|June 9, 2025
High Temperature Requirement Protein A1-Positive Membranous Nephropathy in a Patient With Chronic Lymphocytic LeukemiaLadan Zand, Fernando C Fervenza, Sanjeev Sethi
Pageof 35